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Abstract 
Cell-free extract and purified enzyme-based systems provide an attractive solution to study 
biosynthetic strategies towards a range of chemicals. 4-(4-hydroxyphenyl)-butan-2-one, also 
known as raspberry ketone, is the major fragrance component of raspberry fruit and is used 
as a natural additive in the food and sports industry. Current industrial processing of the natural 
form of raspberry ketone involves chemical extraction with a yield of ~1-4 mg kg-1 of fruit. Due 
to toxicity, microbial production provides only low yields of up to 5-100 mg L-1. Herein, we 
report an efficient cell-free strategy to probe a synthetic enzyme pathway that converts either 
L-tyrosine or the precursor, 4-(4-hydroxyphenyl)-buten-2-one (HBA), into raspberry ketone at 
up to 100% conversion. As part of this strategy, it is essential to recycle inexpensive cofactors. 
Specifically, the final enzyme step in the pathway is catalysed by raspberry ketone/zingerone 
synthase (RZS1), an NADPH-dependent double bond reductase. To relax cofactor specificity 
towards NADH, the preferred cofactor for cell-free biosynthesis, we identify a variant (G191D) 
with strong activity with NADH. We implement the RZS1 G191D variant within a ‘one-pot’ cell-
free reaction to produce raspberry ketone at high-yield (61 mg L-1), which provides an 
alternative route to traditional microbial production. In conclusion, our cell-free strategy 
complements the growing interest in engineering synthetic enzyme cascades towards 
industrially relevant value-added chemicals.  
Introduction 
Cell-free systems offer an intriguing solution to reconstitute metabolic pathways without the 
genetic constraints of a living cell. The definitions of cell-free systems vary in the literature and 
include the use of pure enzymes1–4 or cell extracts enriched with heterologous enzymes5–8, 
while alternatively, metabolic enzymes can also be generated in situ through cell-free protein 
synthesis5,9. These combined approaches present an alternative concept to traditional cell 
based metabolic engineering, with the potential for efficient biosynthesis of complex natural 
products7,10,11, screening of biosynthetic enzymes5,6,12, optimising cofactor regeneration 
schemes1,12,13 or probing biosynthetic promiscuity14. However, before cell-free technologies 
can be used for the synthesis of lower value-added products such as fine chemicals there are 
several aspects that need to be addressed including cost, scalability and the longevity of the 
extract or purified enzymes. In this short communication, we focus on examining the feasibility 
of enzyme biosynthesis of 4-(4-hydroxyphenyl)butan-2-one – also referred to as raspberry 
ketone – a fine chemical from raspberry berries (Rubeus rubrum). 
 
Raspberry ketone is harvested via a highly inefficient extraction from raspberry fruit, at an 
approximate yield of ~1-4 mg per kg of fruit, which leads to a high market value of 
approximately $10,000-20,000 per kg and global production estimated at between 100-200 
tons per annum15. The natural raspberry ketone biosynthetic pathway is not fully resolved, but 
is derived from L-tyrosine or phenylalanine and belongs to the plant flavonoid natural product 
family, which includes curcumin, naringenin, resveratrol and gingerole16. To make raspberry 
ketone, a combination of plant, fungal and bacterial enzymes can be used, starting from p-
coumarate15. Firstly, p-coumarate is activated for acyl chain extension by the addition of CoA 
by an ATP-dependent CoA ligase (PCL) to form p-coumaroyl-CoA17. Following this, the 
benzalacetone synthase (BAS) uses malonyl-CoA for acylation, which includes an unusual 
double decarboxylation event to afford the 4-(4-hydroxyphenyl)-buten-2-one intermediate, 
also referred to as 4-hydroxybenzalacetone (HBA)18. Finally, a NADPH-dependent raspberry 
ketone/zingerone synthase (RZS1), a double bond reductase, reduces HBA into raspberry 
ketone19. At present, despite its simplicity, raspberry ketone is a challenging molecule to make 
through microbial production. Key limitations include malonyl-CoA regeneration20 and the 
general metabolic toxicity (through growth inhibition) of the raspberry ketone pathway 
intermediates15. Therefore, current microbial fermentation strategies, starting from p-
coumarate have produced limited yields in either E. coli or Saccharomyces cerevisiae, ranging 
from 0.2 to 95 mg L-1 15,21–23, which largely rely upon growth media optimisation and maximising 
cell density to overpower general toxicity issues from ketone intermediates. Or to indirectly 
overcome growth inhibition, recently Yang et al used a E. coli whole-cell catalyst approach to 
make up to 9 g L-1 of raspberry ketone from HBA24. However, this strategy bypasses the 
polyketide step and incubates E. coli cells containing a pre-expressed RZS1 and a glucose 
dehydrogenase for NADPH regeneration, in an optimised reaction buffer with HBA24. 
 
Herein, we establish an alternative ‘one-pot’ multienzyme approach for making raspberry 
ketone from L-tyrosine with cofactor regeneration, in order to study biosynthetic dexterity 
outside the constraints of a living cell. One of the essential considerations for cell-free 
biosynthesis, is the cofactor costs. While a range of low-cost cofactor regeneration systems 
are available25, the expense and chemical stability of specific cofactors such as NADPH is a 
limitation. For ‘one-pot’ raspberry ketone biosynthesis, optimal conversion was initially 
obtained with NADPH, while minimal yields were observed with NADH, due to unfavourable 
kinetic properties of RZS1 for NADPH. This is important since the bulk price per mole of NADH 
($3,000) is a fraction of NADPH ($215,000)26. Therefore, to lower the overall cost of cell-free 
raspberry ketone synthesis, a key focus of our current work was to relax the cofactor specificity 
of RKS1, which has previously been achieved for other reductases1,27. We do this by obtaining 
a stable ternary structure of RKS1 in complex with NADPH and HBA, which we then use to 
rationally engineer the cofactor preference of RKS1 towards NADH. Finally, we employ this 
new engineered RKS1 variant (G191D) to establish a multienzyme ‘one-pot’ raspberry ketone 
biosynthesis from inexpensive precursors.  
Materials and Methods 
 
Molecular biology and protein expression 
Raspberry ketone and cofactor regeneration genes (see supporting information) were 
synthesised by ThermoFisher Scientific and codon optimised for E. coli K12 expression with 
compatibility for EcoFlex cloning using routine methods28. All oligonucleotides, plasmids and 
synthetic DNA sequences are listed in the supporting information (Table S4 and S5). 
Sequencing was performed by Eurofins, Germany. 
 
Golden Gate Mutagenesis 
We developed a new protocol for mutagenesis based on Golden Gate cloning. Forward and 
reverse primers were designed for inverse PCR of the plasmid (pET15b-RZS1) to incorporate 
a BsaI site. After digestion with BsaI, the restriction sites are removed, leaving a 
complementary 4 bp overhang, which is designed to incorporate the mutation site. This 
anneals and ligates to provide the desired mutation. PCR was performed with the Q5 
polymerase (NEB) with 3% (v/v) DMSO using the manufacturers standard guidelines. PCR 
was run on a 1% (w/v) agarose gel and the bands were excised and gel purified with a 
QIAquick Gel Extraction Kit. 20 ng of PCR product was then digest and ligated in a ‘one-pot’ 
reaction with 1× DNA ligase buffer (Promega), 1 unit of BsaI-HF, 5 units of T4 ligase and 1 
unit of DpnI. The reaction was run for 15 cycles at 37°C for 5 min and 16°C for 10 min, followed 
by a further incubation at 50°C for 5 min and 80°C for 5 min. 20 L of DH10 competent cells 
were transformed with 2 L of ligation mix and plated onto 100 g mL-1 carbenicillin plates. 
Single colonies were then sequence verified for incorporation of the mutation site. 
 
Protein expression and purification 
His6-tagged recombinant TAL, PCL, BAS, MatB and RZS1 were over-produced in E. coli 
BL21-Gold (DE3) grown at 37°C, 200 rpm in 2YT medium with 100 g mL-1 ampicillin until an 
OD600 of 0.6 was reached. Cells were induced with 0.4 mM IPTG and grown overnight at 21°C 
at 200 rpm. Cell were collected by centrifugation at 6,000 × g, 4°C for 20 min, then re-
suspended in binding buffer (20 mM Tris-HCl pH 8, 500 mM NaCl, 5 mM imidazole) and lysed 
by sonication. Cell-lysates were clarified with centrifugation at 45,000 × g, 4°C for 20 min and 
purified by gravity flow using Ni-NTA agarose (Generon). His6-tagged proteins were washed 
with increasing concentrations of imidazole (5, 30 and 70 mM) in 20 mM Tris-HCl pH 8, 500 
mM NaCl, before elution at 400 mM imidazole. Purified proteins were then dialysed (MWCO 
10,000) into 2 litres of 20 mM HEPES pH 7.5, 100 mM NaCl at 4°C for 6 hrs. The enzymes 
were found to be soluble and active in a range of standard buffers including HEPES (pH 7.5) 
and Tris-HCL pH 8.0-9.5. Additionally, all enzymes were stable for long-term storage at -80°C 
with 15% (v/v) glycerol. 
 
Chemical synthesis of HBA 
HBA, also referred to as 4-(4-hydroxyphenyl)-buten-2-one was synthesised by a crossed aldol 
condensation as previously described23,29. 
 
LC-MS of raspberry ketone and pathway intermediates 
50 L samples of time-course reaction in triplicate were removed and inactivated with 450 L 
of 1% (v/v) HCl. Samples were centrifuged at 21,000 × g for 10 min at room temperature. The 
supernatant was directly analysed by liquid-chromatography mass spectrometry (LC-MS), 
performed with an Agilent 1290 Infinity system with an online diode array detector in 
combination with a Bruker 6500 quadruple time-of-flight (Q-ToF) mass spectrometer. An 
Agilent Extend-C18 2.1 x 50mm (1.8 m particle size) column was used at a temperature of 
25 C with a buffer flow rate of 0.2 mL-1 min-1. LC was performed with a linear gradient of buffer 
A [0.1% (v/v) formic acid] and buffer B [0.1% (v/v) formic acid in acetonitrile]. Separation was 
achieved using 5% (v/v) buffer B for 2 min, followed by a linear gradient to 50% (v/v) buffer B 
from 2-9 min, which was held at 50% (v/v) buffer B from 9-10 min. Spectra were recorded 
between a mass range of 90-1000 m/z at a rate of 3 spectra per second. Standards were 
prepared and calibration curves for the intermediates L-tyrosine, p-coumaric acid, HBA and 
raspberry ketone were derived. Quantitation was based on the MS peak area of precursor or 
fragment ion in comparison to the analytical standards. Under the conditions used, raspberry 
ketone is detected as a sodium adduct [M+Na+]+ or as a diagnostic fragment ion at m/z= 
107.49, corresponding to C7H7O. For the standards in solvent, good linearity (R2>0.99) was 
achieved over the range of 0.3 to 30 pmol on column. The lower limit of quantitation was set 
at 0.3 pmol. Samples that were below this limit were repeated by increasing the injection 
volume to 1 L. Due to a lack of an analytical standard and poor separation, p-coumaroyl-CoA 
was not quantified. 
 
Enzyme kinetics 
RZS1 and mutants were purified to homogeneity using nickel IMAC and buffer exchanged into 
Buffer A. Steady-state kinetics were monitored on a Clariostar (BMG) plate-reader monitoring 
absorbance at 340 nm following the reduction of NAD(P)H to NAD(P)+ with either 4-
hydroxyphenyl-3-butan-2-one (hydroxybenzaldehyde) or phenyl-3-butan-2-one 
(benzaldehyde) as substrates. Assays were performed in triplicate at 30C in 0.1 M potassium 
phosphate pH 6.4. 
 
RZS1 crystallisation and structure determination 
IMAC purified RZS1 was dialysed for 4 hrs in 20 mM Tris-HCl pH 8.0 and 200 mM NaCl. 
Purified fractions were concentrated with a 10,000 MWCO centrifugation concentrator 
(Amicon) and then separated by analytical Superdex S200 gel filtration column (GE 
Healthcare) in the same buffer with a flow-rate of 1 mL min-1. Purity was assessed by SDS-
PAGE and the concentration was determined by A280 measurement using an extinction 
coefficient of 44,030 M-1 cm-1. RZS1 was concentrated to 10 mg mL-1 and screened in a range 
of crystallisation conditions using 300 nL drops containing either a ratio of 1:2 or 2:1 of protein 
and reservoir buffer. Crystals of N-terminally His6-tagged RZS1 were obtained by sitting drop 
vapour diffusion at 20°C after ~3 days of incubation in 0.1 M MES/imidazole pH 6.3, 11% (w/v) 
PEG 550 MME and 5% (w/v) PEG 20K, 20 mM of amino acid mixture (Molecular dimensions 
Morpheus system) with 1 mM NADPH. Single cube-shaped crystals grew within 1 week. 
Native crystals with NADPH bound were soaked in cryoprotectant containing 1 mM HBA, 1 
mM NADPH and 20% glycerol. A native dataset of 1800 frames was collected remotely at the 
I04 beamline (Diamond Light Source, Didcot, Oxfordshire) from a single crystal diffracting up 
to ~1.5 Å. The crystal belonged to space group P1 (Table S1). Further details on structure 
determination are provided in the supporting information. The atomic coordinates and 
structure factors (codes: 6EOW for the ternary structure) has been deposited in the Protein 
Data Bank.  
Results 
‘One-pot’ biosynthesis of raspberry ketone without cofactor recycling 
In order to study the biosynthesis of raspberry ketone, we selected a synthetic five-step 
pathway for raspberry ketone using a combination of bacterial, fungi and plant enzymes 
(Figure 1A). Based on this synthetic pathway, a set of highly active and well-characterised 
enzymes. Rhodotorula glutinis TAL30 and Arabidopsis thaliana PCL17 were selected from the 
BRENDA database (see methods) to afford p-coumaroyl-CoA from L-tyrosine, along with the 
Rhodopseudomonas palustris MatB31 for provision of malonyl-CoA from malonate, CoA and 
ATP. In addition, we also selected the Rheum palmatum BAS18 and Rubreus rubrum RZS119, 
where only a single enzyme has been reported for conversion of p-coumaroyl-CoA into 
raspberry ketone. Initially, each enzyme was recombinantly produced in E. coli BL21 Gold 
(DE3) pLysS and purified at high-yields (~10-100 mg L-1) from the soluble fraction with at least 
95% purity as estimated by SDS-PAGE (Figure 1B). The activity of TAL, PCL and RZS1 
enzymes was also assayed individually (Figure S1) and results were in close agreement to 
previous reported literature values17,19,30. 
 
To begin, we tested a ‘one-pot’ reaction with 5 M of purified TAL, PCL, MatB, BAS and RZS1 
enzymes incubated with 1 mM L-tyrosine and substrates/cofactors (MgATP, CoA, malonate 
and NADPH). Please refer to the materials and methods for further reaction conditions. 
Samples were removed at time points and quantified by reverse phase (C18) liquid-
chromatography mass spectrometry (LC-MS) (Figure 1B). To begin, L-tyrosine is steadily 
depleted, whilst p-coumarate accumulates up to a maximum of 110 M. Under these 
conditions, the HBA intermediate was not detectable, with the RZS1 fully converting its 
substrate into raspberry ketone. Raspberry ketone biosynthesis occurred at an initial linear 
rate of 0.63 M min-1 for up to 6 hrs, with a 33.7% conversion (337 M) achieved at end-point, 
which is equivalent to 55 mg L-1 raspberry ketone under batch synthesis. This suggests that 
the synthetic pathway was highly active, which was intriguing based on the relatively low-
productivity observed in cell-based metabolic engineering efforts (from 0.28 mg L-1 and 95 mg 
L-1 in yeast and E. coli, respectively)15,21–23.  
 
Cofactor Engineering of the RZS1 enzyme for NADH preference 
Next, we focused our attention on relaxing the NADPH specificity of the RZS1 enzyme. RZS1 
catalyses the NADPH-dependent double bond reduction of HBA into raspberry ketone. For 
cell-free based biocatalysis, NADH or biomimetic analogues32 are preferred to provide 
increased stability and reduced cost for reductive enzyme reactions. We therefore repeated 
the ‘one-pot’ biosynthesis of raspberry ketone with NADH in place of NADPH as a cofactor 
(Figure S2-3). In this reaction, the rate of L-tyrosine deamination by TAL remained constant, 
and an increased accumulation of p-coumarate (172 M) and HBA (15 M) is observed after 
6 hrs, with only trace levels of raspberry ketone detected. After 48 hrs, a 7.6% (76.1 M) 
conversion of raspberry ketone was achieved. The initial lag in raspberry ketone accumulation 
confirmed that the RZS1 enzyme had a clear preference for NADPH as a cofactor. 
 
To further understand the RZS1 reductase, the enzyme was next characterised in vitro. Firstly, 
HBA the natural substrate for RZS1 is yellow in colouration at pH >6 and strongly absorbs 
between 250-450 nm, which overlaps with NAD(P)H absorbance at 340 nm for kinetic 
characterisation. Instead, to initially obtain kinetic parameters for the RZS1 enzyme, the 
substrate analogue phenylbuten-2-one was used since it lacks UV-Visible absorbance at 340 
nm. To begin, the RZS1 enzyme shares sequence similarity (77% amino acid identity) and 
similar kinetic properties to the previously characterised promiscuous Nicotiana tabacum 
double bond reductase NtDBR33. For example, both RZS1 and NtDBR share increased activity 
towards acidic pH conditions (Figure S4). For all further RZS1 enzyme assays, these were 
measured at 30°C and pH 6.4, with 1 mM of phenylbuten-2-one. Under these conditions, RZS1 
shows an apparent Kcat/Km of 58- and 1.3-mM s-1 mM-1 with NADPH and NADH, respectively 
(Table S3). 
 
About 10% of all known oxidoreductase enzymes, particularly from secondary metabolism, 
have a distinct preference for NADPH34. A number of studies have also highlighted that the 
cofactor specificity of NADPH-dependent reductase enzymes can be relaxed towards NADH 
preference by increasing the interaction of the enzyme with the ribose 5’-hydroxyl group 
(NADH)1,27. To aid in the rational design of increasing NADH activity of the RZS1 enzyme, we 
crystallised and solved the tertiary structure complex of RZS1 with raspberry ketone pathway 
substrate HBA (Figure 2A) and the cofactor NADPH (Figure 2B), deposited as pdb:6EOW. By 
analysing the 2F0 – Fc Fourier syntheses, two configuration states were observed at a 50:50 
ratio due to crystal soaking. The mixed states could be as a result of NADPH and ternary 
complex formation to the active site, thus displacing any NADP+ present from crystallisation. 
In the ternary complex state, additional electron density for HBA binding is observed, with 
face-to-face - stacking between the HBA and nicotinamide aromatic rings (Figure S5) with 
a hydride transfer distance of 3.06 Å to the alkene double bond. Furthermore, in the ternary 
complex, an additional patch of electron density consistent of a flexible loop supporting Y72 is 
observed. This flexible loop forms a cap over the active site (closed loop), with the para 
hydroxyl group in HBA moving towards Y72. With respect to HBA binding, the substrate is 
bent within the active site and is encased by aromatic residues Y59, Y72, Y85, F107, Y263 
and F290 (Figure S5). We speculate that this closed loop formation holds the HBA within the 
active site prior to transition state. Interestingly, in contrast to apo-RZS1 and NtDBR, the Y72 
flexible loop lacks electron density and seemingly points away from the active site (open loop 
state). Finally, in regards to cofactor binding, in both states the NADP(H/+) cofactor is bound 
in a typical conformation as is observed in the previous related structures33 with the binding 
specificity provided by a triad of hydrogen bond based contacts with the G191 backbone 
nitrogen and the side chains K195 and Y211 (Figure S5). While K212 is also present, it is 
rather removed from binding to the ribose 5’-phosphate. Importantly, K195 can interact with 
either the ribose 5’-phosphate or neighbouring 4’-hydroxyl group. 
 
In an effort to modify the cofactor specificity of the RZS1 enzyme, amino acid substitutions at 
G191 (Table S3) and Y211 (data not shown), and steady-state kinetics was determined 
(Figure 2 and Table S3). We did not attempt to modify K195 due to its potential role in bonding 
to the 4’ hydroxyl group found in both NADPH and NADH. We instead chose to modify G191 
to provide a short polar side chain (D and N) that can provide a hydrogen bond for the 5’-
hydroxyl group unique to NADH. Both the D191 and N191 modifications decreased the kcat/Km 
from 58 mM-1 s-1 (RZSWT) with NADPH to 14 and 15 (s-1 mM-1), respectively (Figure 2C, D). 
This decrease in catalytic efficiency was due to an increased Km for NADPH with the variants. 
Interestingly, for N191, the kcat increased by 3-fold up to 1.07 s-1 in comparison to the wild-
type (0.31 s-1). One possible interpretation is that steric hindrance of N191 with the 5’ 
phosphate increases the catalytic rate by enhancing NADP+ release through decreasing its 
binding affinity. In contrast, with NADH as the cofactor, while N191 did not improve NADH 
specificity, D191 was found to favourably increase the kcat/Km from 1.3 mM-1 s-1 (RZSWT) to 5.9 
mM-1 s-1 (Figure 2 and Table S3). In summary, substitutions at G191 that are negatively 
charged (D), improve NADH specificity in preference to a positive charged residue (N). While 
further modifications to the Y211 position were also tested individually or in combination with 
D191 and N191 (data not shown), no further improvements in NADH specificity or kcat were 
found, with modifications leading to a reduction in specific activity with either NADH or NADPH. 
 
NADH based enzymatic synthesis of raspberry ketone from HBA 
The kinetics of RZS1 (wild-type and D191) were not characterised with its natural substrate, 
HBA. Instead, we studied its activity with HBA and NAD(P)H cofactor regeneration in a ‘one-
pot’ reaction. Firstly, HBA was synthesised from the inexpensive substrates p-benzaldehyde 
and acetic acid using an aldol condensation reaction under basic conditions to provide a 76% 
yield (Figure 3A and Figure S6). Then, using the thermostable phosphite dehydrogenase 
(PtxD) mutant opt1235 for NAD(P)H regeneration from phosphite, we tested the reduction of 
the HBA substrate at 30C by following a loss of absorbance at 400 nm (A400). For negative 
controls, in the absence of the reductase, phosphite or PtxD, the A400 for 1 mM HBA remained 
stable over the time-course measured (Figure 3B). With 1 mM HBA, 10 M of RZS1, 20 mM 
phosphite and an excess of PtxD opt12, complete reduction was achieved with as little as 10 
M of NADPH (Figure 3). Next, to demonstrate the proficiency of the RZS1 variants (10 M) 
with both NADPH and NADH, a time-course reaction was monitored with 1 mM injections of 
HBA every hr with 0.25 mM NAD(P)H, 20 mM phosphite and an excess of PtxD opt12 (Figure 
3C). For RZS1WT, an initial rate of 59.1 and 12.8 M min-1 mg-1 was observed with NADPH 
and NADH, respectively (Table 2). In comparison, for RZS1D191, the rates of reduction with 
NADPH and NADH were nearly equivalent at 46.5 and 43.5 min-1 mg-1, respectively (Table 2). 
This demonstrated highly efficient synthesis of raspberry ketone, with the RZSD191 variant 
providing an elevated and complete turnover (~100%) with the inexpensive NADH cofactor. 
We also found that RZS1 reductase activity lasted for several days at room temperature, which 
is a desirable property for cell-free enzyme biosynthesis (data not shown). 
 
NADH based ‘one-pot’ biosynthesis of raspberry ketone from L-tyrosine 
To understand whether the RZS1D191 variant could be used for cell-free synthesis of raspberry 
ketone with NADH, three time-course reactions were prepared with 1 mM L-tyrosine and 
optimised enzyme levels and cofactors with either an absence of the reductase or a 
combination of RZS1WT/NADPH or RZS1D191/NADH. Without RZS1, the reaction accumulated 
HBA at a rate of 0.81 M min-1 (Table 2), with a maximum conversion of 421 M observed 
after 48 hrs, along with 197 M of leftover p-coumarate. By adding 20 M RZS1WT with 0.5 
mM NADPH along with cofactor recycling with the phosphite dehydrogenase35, in contrast, a 
linear rate of raspberry ketone synthesis of 0.38 M min-1 was observed. After 48 hrs, the final 
concentrations of the intermediates were 291 M p-coumarate and 375 M raspberry ketone, 
while no L-tyrosine or HBA was detected (Figure 4). The HPLC chromatogram trace 
suggested that the remaining mixture was composed of the bisnoryangonin side product, 
previously shown as a minor side-product by the BAS enzyme at low pH36. In contrast, with 
20 M RZS1D191 introduced under the same conditions, the final level of raspberry ketone 
synthesis was improved to 279 M at a rate of 0.51 M min-1, with a mixture of 297 M p-
coumarate and 198 M HBA remaining (Figure 4).  
Discussion 
The related areas of cell-free synthetic biology and synthetic biochemistry offer an exciting 
opportunity to design and engineer enzyme pathways outside of the constraints of a living cell. 
Recent advances include the generation of a synthetic CO2 fixation cycle37 and the 20,000 L 
scale-up biosynthesis of inositol38. Natural products and other high-value fine chemicals are 
often only synthesized at very low concentrations in their natural source. Therefore, there is 
an accelerating interest in developing biosustainable routes for a range of high-value fine 
chemicals.  For raspberry ketone, only tiny quantities are synthesised in the berries 
themselves and the process requires weeks of maturation. While the raspberry ketone 
intermediates in general inhibit microbial growth production, this can be bypassed using a E. 
coli whole-cell (stationary phase cells) biocatalyst system which is active to the g L-1 scale, but 
requires the chemically derived precursor HBA24. Alternatively, the substrates L-tyrosine or p-
coumarate, which can be derived from a natural feedstock, can be converted by the type III 
polyketide described herein, in synthetically engineered E. coli and S. cerevisiae systems but 
yields are limited (up to 95 mg L-1) due to general toxicity15,21,22.  
 
Herein, we have investigated an alternative cell-free ‘one-pot’ multienzyme system for the 
biosynthesis of raspberry ketone. Raspberry ketone, although one of the simpler polyketides, 
still has a biosynthetic pathway that requires the expensive cofactors ATP, malonyl-CoA, and 
NAD(P)H. By studying this system outside of the cell, this allows the precise control of enzyme 
levels, and flexible testing of different cofactor recycling systems. We demonstrate that 
raspberry ketone can be synthesised efficiently from a five-step enzyme pathway from L-
tyrosine, however, yields with the most cost-effective cofactor, NADH, were limited. Therefore, 
to reduce a key cost-factor, NADPH, a key focus of our work, was to relax the cofactor 
specificity of the RZS1 double bond reductase towards NADH. A number of studies have 
highlighted that NADPH oxidoreductases can be engineered to use the more stable and 
inexpensive NADH27 or biomimetic analogs32. As a generalised approach, the structure-guided 
design of NAD(P)H enzymes can be rationalised by altering the affinity for the ribose 5’-
phosphate (NADPH) or hydroxyl (NADH) group27. In the case of the RZS1 enzyme, position 
G191 provides flexible control for engineering relaxed cofactor specificity. Its coupled use with 
an inexpensive phosphate donor via the phosphite dehydrogenase35 thus affords a low-cost 
route to raspberry ketone synthesis in cell-free conditions with NADH using any of the three 
starting substrates described. Importantly, the RZS1 G191D variant is efficient at low levels of 
NADH (10 M) and remains active for several days. By substituting this enzyme into the 
complete ‘one-pot’ multienzyme system, we can obtain a maximum yield of 61 mg L-1 
raspberry ketone in a batch system with full conversion of the substrate L-L-tyrosine (300 M 
or 54 mg L-1) into raspberry ketone. At higher concentrations of L-tyrosine, despite attempts 
to optimise cofactor and ATP levels (data not shown), we observe accumulation of pathway 
intermediates and the side-product bisnoryangonin. Finally, we also demonstrate an efficient 
two-step chemoenzymatic approach to raspberry ketone. This is similar to the strategy 
employed by Yang et al23, which reaches a product that is ‘nature identical’ and of lower 
economic value, due to the requirement to chemically synthesise HBA. Therefore, to make 
natural raspberry ketone, the five-step pathway is of greater interest if scalability can be 
demonstrated. However, either further engineering of the BAS enzyme, the characterisation 
of new BAS homologs, or the development of alternative enzyme pathways is required. This 
is since the catalytic activity of BAS is rate-limiting and it also produces an undesired side-
product, bisnoryangonin, in our optimised reactions. 
 
While a full technoeconomic analysis is outside the scope of the current work, a cell-free 
enzymatic approach to fine chemical synthesis could provide benefits in terms of sustainability.  
Approximately 80% of the fine chemical market that is used for cosmetics and food additives, 
is currently produced by oil derived chemical synthesis and thus approved for use if declared 
as ‘nature-identical’39. For fine chemicals that are extracted naturally from food sources that 
require large agricultural landmasses, therefore, potentially it is far simpler and more 
sustainable to engineer greener alternative biocatalytic platforms, either from the use of 
engineered plants and microbes or through scaled-up cell-free systems.  The use of purified 
enzymes compared to whole-cell processes for production might offer benefits in terms of 
control over side reactions, ease of purification because of fewer contaminating metabolites, 
or for situations where the toxicity of the product limits cell growth.  However, the costs of 
enzyme production and purification, along with the need to add expensive cofactors that would 
normally be generated from medium components within cells does lead to increased costs. 
Strategies such as immobilisation of the enzymes to enable recycle and reuse, could 
potentially be employed to achieve economic viability40. 
 
Here, using raspberry ketone as a model pathway, we have demonstrated how an apparently 
non-productive enzyme pathway can be engineered to a high level of performance from 
outside of the cell. Essential to this process is the ability to study enzyme pathways in 
completion, rather than as individual uncoupled kinetics, since shared resources (CoA, ATP) 
can impact overall yields. In summary, cell-free synthetic biology provides an expandable 
opportunity to design synthetic enzyme ensembles in unison with cofactor availability. We 
have applied this rational to optimise raspberry ketone, a small molecule that is not easily 
obtained from within engineered living cells. In the future, scaled-up cell-free engineering 
approaches38 with highly stable and active enzymes, have the potential to play a broader role 
to compete with traditional cell-based engineering, particularly for the high-value fine 
chemicals, recombinant proteins and natural products5.  
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Figures 
 
Figure 1. A cell-free module for raspberry ketone biosynthesis. A. A synthetic pathway 
for raspberry ketone synthesis from L-tyrosine using malonate for malonyl-CoA synthesis. B. 
SDS-PAGE of pathway enzymes. 2 g of purified enzyme was loaded and analysed by 12% 
(v/v) SDS-PAGE and Coomassie Blue staining. Sizes of His6-tagged recombinant enzyme - 
R. glutinis TAL (77.0 kDa), A. thaliana PCL (63.2 kDa), R. palustris MatB (56.6 kDa), R. 
palmatum BAS (44.4 kDa), R. rubrum RZS1 (40.7 kDa). C. ‘One-pot’ biosynthesis of raspberry 
ketone with 2.5 M of enzymes under standard conditions. For full details see Table S2. 
Intermediates quantified by LC-MS include L-tyrosine (white box), p-coumarate (yellow box), 
HBA (orange box) and raspberry ketone (red box). Data is representative of three technical 
repeats. 
 
Figure 2. Structure based engineering of the RZS1 reductase with increased NADH 
specificity (pdb: 6EOW). A. Binding site for HBA in proximity to the NADPH cofactor. B. 
Cofactor specificity is provided by a triad of binding residues G191, K195 and Y211 with 
hydrogen bonding to the 5’-ribose phosphate. C. NADPH kinetics with RZS1 G191 variants. 
D. NADH kinetics with RZS1 G191 variants. 
 
Figure 3. A two-step semi-synthetic route to high-yield raspberry ketone synthesis with 
NADH and cofactor regeneration. A. A semi-synthetic pathway for raspberry ketone using 
aldol condensation and RZS1 reductase activity with cofactor regeneration. B. Activity of the 
thermostable PtxD opt12 phosphite dehydrogenase with 1 mM HBA and 10 M RZS1. 
Negative controls (no enzyme or phosphite) are shown along with a variable concentration of 
NADPH. C. Time-course reaction monitoring loss of absorbance at 400 nm showing reduction 
of HBA to raspberry ketone. Injections of 1 mM HBA were added in 60 min cycles. An excess 
of PtxD and 20 mM phosphite was incubated at 30C with 10 M RZS1 (top panel) or the 
D191 variant (bottom panel), with either 0.25 M NADPH (blue line) or NADH (red line). 
 
Figure 4. ‘One-pot’ biosynthesis of raspberry ketone under optimised enzyme levels 
and cofactor regeneration. (A) Reaction with RZS1WT and NADPH. (B) Reaction with 
RZS1D191 and NADH. Reaction conditions are provided in Table S2. 
